+Follow
咸蛋超人POT
股票呆呆
10
Follow
4
Followers
0
Topic
0
Badge
Posts
Hot
咸蛋超人POT
2022-12-15
BBQ ler
Sorry, the original content has been removed
咸蛋超人POT
2021-12-23
The drug ha side effects
Sorry, the original content has been removed
咸蛋超人POT
2021-12-18
Time to trap the short sellers
Sorry, the original content has been removed
咸蛋超人POT
2021-09-03
$Cassava Sciences Inc(SAVA)$
It's almost time to average in at current price levels. Baby steps at a time, go easy. [YoYo] [Call]
咸蛋超人POT
2021-08-28
$Cassava Sciences Inc(SAVA)$
Lunch break isover, time to go GREEN![Smart]
咸蛋超人POT
2021-08-28
$Cassava Sciences Inc(SAVA)$
SQUEEZE the BEARS!!!
咸蛋超人POT
2021-08-27
$Cassava Sciences Inc(SAVA)$
Cassava Sciences Releases Statement Regarding Plasma p-tau (globenewswire.com)
咸蛋超人POT
2021-04-29
$Castor Maritime, Inc.(CTRM)$
have put this ticker in storage; will look back on it months later :O
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3575010783330312","uuid":"3575010783330312","gmtCreate":1612181250199,"gmtModify":1636088794261,"name":"咸蛋超人POT","pinyin":"xdcrpotxiandanchaorenpot","introduction":"","introductionEn":null,"signature":"股票呆呆","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":10,"tweetSize":24,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.14%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.94%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":9921593734,"gmtCreate":1671080909728,"gmtModify":1676538487015,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"BBQ ler","listText":"BBQ ler","text":"BBQ ler","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9921593734","repostId":"2291796194","repostType":2,"isVote":1,"tweetType":1,"viewCount":389,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9000230410,"gmtCreate":1640191181689,"gmtModify":1676533506185,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"The drug ha side effects","listText":"The drug ha side effects","text":"The drug ha side effects","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000230410","repostId":"1104039472","repostType":4,"isVote":1,"tweetType":1,"viewCount":492,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9000976274,"gmtCreate":1639789385814,"gmtModify":1676533494531,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"Time to trap the short sellers","listText":"Time to trap the short sellers","text":"Time to trap the short sellers","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000976274","repostId":"1108682296","repostType":2,"isVote":1,"tweetType":1,"viewCount":440,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":815834802,"gmtCreate":1630664153206,"gmtModify":1676530369992,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>It's almost time to average in at current price levels. Baby steps at a time, go easy. [YoYo] [Call] ","listText":"<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>It's almost time to average in at current price levels. Baby steps at a time, go easy. [YoYo] [Call] ","text":"$Cassava Sciences Inc(SAVA)$It's almost time to average in at current price levels. Baby steps at a time, go easy. [YoYo] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/815834802","isVote":1,"tweetType":1,"viewCount":398,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819437902,"gmtCreate":1630085057706,"gmtModify":1676530221747,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>Lunch break isover, time to go GREEN![Smart] ","listText":"<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>Lunch break isover, time to go GREEN![Smart] ","text":"$Cassava Sciences Inc(SAVA)$Lunch break isover, time to go GREEN![Smart]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/819437902","isVote":1,"tweetType":1,"viewCount":750,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819544328,"gmtCreate":1630080347364,"gmtModify":1676530220694,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a> SQUEEZE the BEARS!!!","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a> SQUEEZE the BEARS!!!","text":"$Cassava Sciences Inc(SAVA)$ SQUEEZE the BEARS!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/819544328","isVote":1,"tweetType":1,"viewCount":362,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819524151,"gmtCreate":1630079037573,"gmtModify":1676530220178,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a> Cassava Sciences Releases Statement Regarding Plasma p-tau (globenewswire.com)","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a> Cassava Sciences Releases Statement Regarding Plasma p-tau (globenewswire.com)","text":"$Cassava Sciences Inc(SAVA)$ Cassava Sciences Releases Statement Regarding Plasma p-tau (globenewswire.com)","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/819524151","isVote":1,"tweetType":1,"viewCount":467,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109878404,"gmtCreate":1619686563408,"gmtModify":1704728003790,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/CTRM\">$Castor Maritime, Inc.(CTRM)$</a> have put this ticker in storage; will look back on it months later :O","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/CTRM\">$Castor Maritime, Inc.(CTRM)$</a> have put this ticker in storage; will look back on it months later :O","text":"$Castor Maritime, Inc.(CTRM)$ have put this ticker in storage; will look back on it months later :O","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/109878404","isVote":1,"tweetType":1,"viewCount":1311,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":109878404,"gmtCreate":1619686563408,"gmtModify":1704728003790,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/CTRM\">$Castor Maritime, Inc.(CTRM)$</a> have put this ticker in storage; will look back on it months later :O","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/CTRM\">$Castor Maritime, Inc.(CTRM)$</a> have put this ticker in storage; will look back on it months later :O","text":"$Castor Maritime, Inc.(CTRM)$ have put this ticker in storage; will look back on it months later :O","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/109878404","isVote":1,"tweetType":1,"viewCount":1311,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819544328,"gmtCreate":1630080347364,"gmtModify":1676530220694,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a> SQUEEZE the BEARS!!!","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a> SQUEEZE the BEARS!!!","text":"$Cassava Sciences Inc(SAVA)$ SQUEEZE the BEARS!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/819544328","isVote":1,"tweetType":1,"viewCount":362,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9000230410,"gmtCreate":1640191181689,"gmtModify":1676533506185,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"The drug ha side effects","listText":"The drug ha side effects","text":"The drug ha side effects","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000230410","repostId":"1104039472","repostType":4,"repost":{"id":"1104039472","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640184691,"share":"https://ttm.financial/m/news/1104039472?lang=&edition=fundamental","pubTime":"2021-12-22 22:51","market":"us","language":"en","title":"Biogen shares fell 1.2% in early trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1104039472","media":"Tiger Newspress","summary":"Biogen shares fell 1.2% in early trading.A Japanese health ministry panel said on Wednesday that inc","content":"<p>Biogen shares fell 1.2% in early trading.<img src=\"https://static.tigerbbs.com/22ab29bf4110d582a44955c778f3cf48\" tg-width=\"713\" tg-height=\"596\" width=\"100%\" height=\"auto\">A Japanese health ministry panel said on Wednesday that inconsistent trial results made it difficult to determine the efficacy of an Alzheimer's treatment developed by Eisai Co and Biogen Inc.</p>\n<p>Tokyo-based Eisai and its United States partner filed for Japanese regulatory approval just over a year ago for the drug Aduhelm, which was approved in the United States in June.</p>\n<p>In a statement the panel cited inconsistent results from global Phase III trials and a lack of clinical significance in the drug's ability to reduce plaques in the brain. The panel said it would take another look if further data is submitted.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen shares fell 1.2% in early trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen shares fell 1.2% in early trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-22 22:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Biogen shares fell 1.2% in early trading.<img src=\"https://static.tigerbbs.com/22ab29bf4110d582a44955c778f3cf48\" tg-width=\"713\" tg-height=\"596\" width=\"100%\" height=\"auto\">A Japanese health ministry panel said on Wednesday that inconsistent trial results made it difficult to determine the efficacy of an Alzheimer's treatment developed by Eisai Co and Biogen Inc.</p>\n<p>Tokyo-based Eisai and its United States partner filed for Japanese regulatory approval just over a year ago for the drug Aduhelm, which was approved in the United States in June.</p>\n<p>In a statement the panel cited inconsistent results from global Phase III trials and a lack of clinical significance in the drug's ability to reduce plaques in the brain. The panel said it would take another look if further data is submitted.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104039472","content_text":"Biogen shares fell 1.2% in early trading.A Japanese health ministry panel said on Wednesday that inconsistent trial results made it difficult to determine the efficacy of an Alzheimer's treatment developed by Eisai Co and Biogen Inc.\nTokyo-based Eisai and its United States partner filed for Japanese regulatory approval just over a year ago for the drug Aduhelm, which was approved in the United States in June.\nIn a statement the panel cited inconsistent results from global Phase III trials and a lack of clinical significance in the drug's ability to reduce plaques in the brain. The panel said it would take another look if further data is submitted.","news_type":1},"isVote":1,"tweetType":1,"viewCount":492,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819524151,"gmtCreate":1630079037573,"gmtModify":1676530220178,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a> Cassava Sciences Releases Statement Regarding Plasma p-tau (globenewswire.com)","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a> Cassava Sciences Releases Statement Regarding Plasma p-tau (globenewswire.com)","text":"$Cassava Sciences Inc(SAVA)$ Cassava Sciences Releases Statement Regarding Plasma p-tau (globenewswire.com)","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/819524151","isVote":1,"tweetType":1,"viewCount":467,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9921593734,"gmtCreate":1671080909728,"gmtModify":1676538487015,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"BBQ ler","listText":"BBQ ler","text":"BBQ ler","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9921593734","repostId":"2291796194","repostType":2,"isVote":1,"tweetType":1,"viewCount":389,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":815834802,"gmtCreate":1630664153206,"gmtModify":1676530369992,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>It's almost time to average in at current price levels. Baby steps at a time, go easy. [YoYo] [Call] ","listText":"<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>It's almost time to average in at current price levels. Baby steps at a time, go easy. [YoYo] [Call] ","text":"$Cassava Sciences Inc(SAVA)$It's almost time to average in at current price levels. Baby steps at a time, go easy. [YoYo] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/815834802","isVote":1,"tweetType":1,"viewCount":398,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819437902,"gmtCreate":1630085057706,"gmtModify":1676530221747,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>Lunch break isover, time to go GREEN![Smart] ","listText":"<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>Lunch break isover, time to go GREEN![Smart] ","text":"$Cassava Sciences Inc(SAVA)$Lunch break isover, time to go GREEN![Smart]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/819437902","isVote":1,"tweetType":1,"viewCount":750,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9000976274,"gmtCreate":1639789385814,"gmtModify":1676533494531,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"Time to trap the short sellers","listText":"Time to trap the short sellers","text":"Time to trap the short sellers","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000976274","repostId":"1108682296","repostType":2,"repost":{"id":"1108682296","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639746579,"share":"https://ttm.financial/m/news/1108682296?lang=&edition=fundamental","pubTime":"2021-12-17 21:09","market":"us","language":"en","title":"Statement Regarding Foreign Media Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=1108682296","media":"Tiger Newspress","summary":"Tiger Brokers is aware of the media reports made today regarding potential regulatory policies related to online brokers and would advise relevant stakeholders to take note of the following:","content":"<p>Tiger Brokers is aware of the media reports made today regarding potential regulatory policies related to online brokers and would advise relevant stakeholders to take note of the following:</p><p>1. Since inception, the firm has always been committed to providing a first-class investment experience for global investors. The firm’s business model is comparable to other brokers in Singapore and Hong Kong and the firm is not conducting any financial services business that is outside standard industry practice. The firm rigidly adheres to all regulatory requirements in the jurisdictions we operate in.</p><p>2. Presently the firm possesses 46 licenses in 36 categories across a wide range of global jurisdictions including Singapore, Hong Kong S.A.R., The U.S., and Australia, among others. The firm continues to execute on its internationalization strategy and in the third quarter of 2021, more than 90% of newly funded accounts were derived from markets outside of mainland China. The firm remains focused on investing in research and development to enable more international investors to enjoy secure, comprehensive and convenient access to global capital markets.</p><p>3. Compliance with laws and regulations is core to the firm’s operations. Should new regulations be introduced in the future, the firm will strictly comply with relevant guidelines and enact new compliance protocols. Furthermore, in the case that relevant authorities promulgate new regulations that have a material effect on our business, the firm will make appropriate disclosures to investors without delay.</p><p>4. Finally, the firm notes that in recent months certain institutions have been disseminating misleading information in order to profiteer from short selling. The firm rejects such malicious short selling activities. We will stay in communication with relevant regulatory authorities and reserve our right to hold those disseminating false information accountable in accordance with the law.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Statement Regarding Foreign Media Reports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStatement Regarding Foreign Media Reports\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-17 21:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tiger Brokers is aware of the media reports made today regarding potential regulatory policies related to online brokers and would advise relevant stakeholders to take note of the following:</p><p>1. Since inception, the firm has always been committed to providing a first-class investment experience for global investors. The firm’s business model is comparable to other brokers in Singapore and Hong Kong and the firm is not conducting any financial services business that is outside standard industry practice. The firm rigidly adheres to all regulatory requirements in the jurisdictions we operate in.</p><p>2. Presently the firm possesses 46 licenses in 36 categories across a wide range of global jurisdictions including Singapore, Hong Kong S.A.R., The U.S., and Australia, among others. The firm continues to execute on its internationalization strategy and in the third quarter of 2021, more than 90% of newly funded accounts were derived from markets outside of mainland China. The firm remains focused on investing in research and development to enable more international investors to enjoy secure, comprehensive and convenient access to global capital markets.</p><p>3. Compliance with laws and regulations is core to the firm’s operations. Should new regulations be introduced in the future, the firm will strictly comply with relevant guidelines and enact new compliance protocols. Furthermore, in the case that relevant authorities promulgate new regulations that have a material effect on our business, the firm will make appropriate disclosures to investors without delay.</p><p>4. Finally, the firm notes that in recent months certain institutions have been disseminating misleading information in order to profiteer from short selling. The firm rejects such malicious short selling activities. We will stay in communication with relevant regulatory authorities and reserve our right to hold those disseminating false information accountable in accordance with the law.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TIGR":"老虎证券"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108682296","content_text":"Tiger Brokers is aware of the media reports made today regarding potential regulatory policies related to online brokers and would advise relevant stakeholders to take note of the following:1. Since inception, the firm has always been committed to providing a first-class investment experience for global investors. The firm’s business model is comparable to other brokers in Singapore and Hong Kong and the firm is not conducting any financial services business that is outside standard industry practice. The firm rigidly adheres to all regulatory requirements in the jurisdictions we operate in.2. Presently the firm possesses 46 licenses in 36 categories across a wide range of global jurisdictions including Singapore, Hong Kong S.A.R., The U.S., and Australia, among others. The firm continues to execute on its internationalization strategy and in the third quarter of 2021, more than 90% of newly funded accounts were derived from markets outside of mainland China. The firm remains focused on investing in research and development to enable more international investors to enjoy secure, comprehensive and convenient access to global capital markets.3. Compliance with laws and regulations is core to the firm’s operations. Should new regulations be introduced in the future, the firm will strictly comply with relevant guidelines and enact new compliance protocols. Furthermore, in the case that relevant authorities promulgate new regulations that have a material effect on our business, the firm will make appropriate disclosures to investors without delay.4. Finally, the firm notes that in recent months certain institutions have been disseminating misleading information in order to profiteer from short selling. The firm rejects such malicious short selling activities. We will stay in communication with relevant regulatory authorities and reserve our right to hold those disseminating false information accountable in accordance with the law.","news_type":1},"isVote":1,"tweetType":1,"viewCount":440,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}